Page last updated: 2024-08-23

escitalopram and Death, Sudden, Cardiac

escitalopram has been researched along with Death, Sudden, Cardiac in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC	1

Other Studies

1 other study(ies) available for escitalopram and Death, Sudden, Cardiac

Article	Year
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:6 Topics: Adult; Antidepressive Agents; Citalopram; Death, Sudden, Cardiac; Escitalopram; Humans; Proton Pump Inhibitors; Renal Dialysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2022

Article

Year

Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.

Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:6

Topics: Adult; Antidepressive Agents; Citalopram; Death, Sudden, Cardiac; Escitalopram; Humans; Proton Pump Inhibitors; Renal Dialysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

2022